Scott Robert Henry sold $8,062 of NXGL
director at NEXGEL, INC.. 3,000 shares at an average of $2.69, traded May 12, 2025, filed May 13, 2025.
Score components
- +15RoleDirector
- 0Trade size$8k at market
- 0Share of holdings soldSold 2.2% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-010033, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 12, 2025 | SOpen-market sale Common Stock10b5-1 | -3,000 | $2.69 | $8,062 | 132,053 | May 13, 2025 |
Related signals
Other insiders at NEXGEL, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | NXGLsell NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $16k 10,000 shares | -3% | |
| 5Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $10k 4,000 shares | -1% | |
| 3Weak | NEXGEL, INC. | Scott Robert Henry director | $20k 8,000 shares | -7% | |
| 13Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $10k 4,000 shares | -1% | |
| 3Weak | NEXGEL, INC. | Scott Robert Henry director | $18k 7,697 shares | -6% | |
| 25Weak | NXGLsell NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $9,896 4,000 shares | -1% | |
| 3Weak | NEXGEL, INC. | Scott Robert Henry director | $7,704 3,000 shares | -2% | |
| 33Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $9,439 4,000 shares | -1% | |
| 33Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $4,613 2,000 shares | -1% | |
| 33Weak | NEXGEL, INC. | Adam R. Levy Chief Executive Officer | $2,220 1,000 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.